1. Clinical Overview
Protamine sulfate is a strongly basic, low molecular weight protein derived from the sperm of salmon and certain other fish species. It is a specific antidote for heparin overdose, acting as a heparin antagonist by forming a stable, inactive complex with heparin (both unfractionated and low molecular weight heparins). This neutralizes the anticoagulant effect. In the Indian context, it is a critical, life-saving drug used in hospital settings, primarily in cardiac surgery, interventional cardiology, dialysis, and other procedures where heparinization is required.
| Onset | Duration | Bioavailability |
|---|---|---|
| Immediate (within 5 minutes following intravenous administration). | Approximately 2 hours. The duration is dependent on body temperature and the dose of protamine relative to heparin. | 100% when administered intravenously (the only approved route). Not absorbed orally. |
2. Mechanism of Action
Protamine sulfate is a polycationic (positively charged) molecule. Heparin is a polyanionic (negatively charged) glycosaminoglycan. Protamine binds ionically to heparin, forming a stable, biologically inactive salt complex (1:1 weight ratio for unfractionated heparin). This neutralizes the anticoagulant effect of heparin by displacing antithrombin III from the heparin-ATIII complex, thereby inhibiting the catalysis of thrombin and factor Xa inhibition.
3. Indications & Uses
- Neutralization of anticoagulant effect of unfractionated heparin during or after cardiopulmonary bypass surgery.
- Neutralization of unfractionated heparin following other surgical procedures (e.g., vascular surgery).
- Management of heparin overdose (accidental or intentional).
4. Dosage & Administration
Adult Dosage: Dose is calculated based on the amount of heparin to be neutralized and the time elapsed since heparin administration. General guideline: 1 mg of protamine sulfate neutralizes approximately 100 USP units of heparin. If heparin was given within 30 minutes, use full calculated dose. If 30-60 minutes have passed, use 0.5-0.75 mg per 100 units heparin. If >2 hours, use 0.25-0.375 mg per 100 units heparin. A single dose should not exceed 50 mg. Administer by slow IV injection over 1-3 minutes (not exceeding 5 mg per minute).
Administration: For IV use only. Must be administered in a hospital setting with resuscitation equipment available. Administer as a slow intravenous injection over 1-3 minutes. Rapid injection can cause severe hypotension, bradycardia, and anaphylactoid reactions. Continuous monitoring of blood pressure, heart rate, and coagulation parameters (ACT/aPTT) is mandatory.
5. Side Effects
Common side effects may include:
- Transient flushing and feeling of warmth.
- Mild hypotension.
- Bradycardia.
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Insulin (NPH, Protamine-based) | Increased risk of hypersensitivity reactions to protamine. | Major |
| Antihypertensive drugs, Vasodilators | Additive hypotensive effect with rapid protamine infusion. | Moderate |
| Heparin | Protamine is an antagonist. This is the intended therapeutic interaction. | N/A |
| Low Molecular Weight Heparins (Enoxaparin, Dalteparin) | Incomplete neutralization. Higher doses of protamine may be required, increasing risk of adverse effects. | Moderate |
7. Patient Counselling
- This drug is administered by a healthcare professional in a hospital. No patient self-administration.
- Inform the doctor/nurse immediately of any history of fish allergy, previous reaction to protamine or NPH insulin, or vasectomy.
- Report any sensation of warmth, itching, difficulty breathing, or chest tightness during or after the injection.
8. Toxicology & Storage
Overdose: Paradoxical anticoagulation and bleeding (due to antithrombin activity of free protamine), severe hypotension, cardiovascular collapse, pulmonary edema.
Storage: Store at a temperature not exceeding 25°C. Protect from light. Do not freeze. The solution for injection should be used immediately after reconstitution. Discard any unused portion. Keep out of reach of children.